Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Kither Biotech, an Italy-based drug development spinout of University of Turin focused on pulmonary disease, has obtained €5.6m ($6.3m) in a series A round featuring Invitalia Ventures, Ersel Wealth Management, Club degli Investitori, Ace Venture, Elysia Capital, the Moschini family office and a number of private investors, including individuals from Italian Angels for Growth. The…

The rest of this content is only accessible to Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.